Report Overview:
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
The Global Opioid Induced Constipation (OIC) Drugs Market Size was estimated at USD 2670.52 million in 2023 and is projected to reach USD 3497.73 million by 2029, exhibiting a CAGR of 4.60% during the forecast period.
This report provides a deep insight into the global Opioid Induced Constipation (OIC) Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Opioid Induced Constipation (OIC) Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Opioid Induced Constipation (OIC) Drugs market in any manner.
Global Opioid Induced Constipation (OIC) Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Market Segmentation (by Type)
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Opioid Induced Constipation (OIC) Drugs Market
? Overview of the regional outlook of the Opioid Induced Constipation (OIC) Drugs Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioid Induced Constipation (OIC) Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Opioid Induced Constipation (OIC) Drugs
1.2 Key Market Segments
1.2.1 Opioid Induced Constipation (OIC) Drugs Segment by Type
1.2.2 Opioid Induced Constipation (OIC) Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Opioid Induced Constipation (OIC) Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Opioid Induced Constipation (OIC) Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Opioid Induced Constipation (OIC) Drugs Market Competitive Landscape
3.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Manufacturers (2019-2024)
3.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Opioid Induced Constipation (OIC) Drugs Sales Sites, Area Served, Product Type
3.6 Opioid Induced Constipation (OIC) Drugs Market Competitive Situation and Trends
3.6.1 Opioid Induced Constipation (OIC) Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Opioid Induced Constipation (OIC) Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Opioid Induced Constipation (OIC) Drugs Industry Chain Analysis
4.1 Opioid Induced Constipation (OIC) Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Opioid Induced Constipation (OIC) Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Opioid Induced Constipation (OIC) Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2019-2024)
6.3 Global Opioid Induced Constipation (OIC) Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Opioid Induced Constipation (OIC) Drugs Price by Type (2019-2024)
7 Opioid Induced Constipation (OIC) Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioid Induced Constipation (OIC) Drugs Market Sales by Application (2019-2024)
7.3 Global Opioid Induced Constipation (OIC) Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Application (2019-2024)
8 Opioid Induced Constipation (OIC) Drugs Market Segmentation by Region
8.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Region
8.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Region
8.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Opioid Induced Constipation (OIC) Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Opioid Induced Constipation (OIC) Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Opioid Induced Constipation (OIC) Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Ironwood Pharmaceuticals Inc
9.1.1 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Basic Information
9.1.2 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Overview
9.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.1.4 Ironwood Pharmaceuticals Inc Business Overview
9.1.5 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs SWOT Analysis
9.1.6 Ironwood Pharmaceuticals Inc Recent Developments
9.2 Daiichi Sankyo Co Ltd
9.2.1 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Basic Information
9.2.2 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Overview
9.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.2.4 Daiichi Sankyo Co Ltd Business Overview
9.2.5 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs SWOT Analysis
9.2.6 Daiichi Sankyo Co Ltd Recent Developments
9.3 Pfizer
9.3.1 Pfizer Opioid Induced Constipation (OIC) Drugs Basic Information
9.3.2 Pfizer Opioid Induced Constipation (OIC) Drugs Product Overview
9.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Progenics Pharmaceuticals Inc
9.4.1 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Basic Information
9.4.2 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Overview
9.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.4.4 Progenics Pharmaceuticals Inc Business Overview
9.4.5 Progenics Pharmaceuticals Inc Recent Developments
9.5 Shionogi and Co., Ltd
9.5.1 Shionogi and Co., Ltd Opioid Induced Constipation (OIC) Drugs Basic Information
9.5.2 Shionogi and Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Overview
9.5.3 Shionogi and Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.5.4 Shionogi and Co., Ltd Business Overview
9.5.5 Shionogi and Co., Ltd Recent Developments
9.6 Allergan Plc
9.6.1 Allergan Plc Opioid Induced Constipation (OIC) Drugs Basic Information
9.6.2 Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Overview
9.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.6.4 Allergan Plc Business Overview
9.6.5 Allergan Plc Recent Developments
9.7 Nektar Therapeutics
9.7.1 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Basic Information
9.7.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Overview
9.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.7.4 Nektar Therapeutics Business Overview
9.7.5 Nektar Therapeutics Recent Developments
9.8 Purdue Pharma
9.8.1 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Basic Information
9.8.2 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Overview
9.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.8.4 Purdue Pharma Business Overview
9.8.5 Purdue Pharma Recent Developments
9.9 S.L.A. Pharma AG
9.9.1 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Basic Information
9.9.2 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product Overview
9.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.9.4 S.L.A. Pharma AG Business Overview
9.9.5 S.L.A. Pharma AG Recent Developments
9.10 Mundipharma International Limited
9.10.1 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Basic Information
9.10.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Overview
9.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.10.4 Mundipharma International Limited Business Overview
9.10.5 Mundipharma International Limited Recent Developments
9.11 Ono Pharmaceutical Co., Ltd
9.11.1 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Basic Information
9.11.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Overview
9.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.11.4 Ono Pharmaceutical Co., Ltd Business Overview
9.11.5 Ono Pharmaceutical Co., Ltd Recent Developments
9.12 Takeda Pharmaceutical Company Limited
9.12.1 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Basic Information
9.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product Overview
9.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.12.4 Takeda Pharmaceutical Company Limited Business Overview
9.12.5 Takeda Pharmaceutical Company Limited Recent Developments
9.13 Theravance Biopharma Inc
9.13.1 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Basic Information
9.13.2 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product Overview
9.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.13.4 Theravance Biopharma Inc Business Overview
9.13.5 Theravance Biopharma Inc Recent Developments
9.14 Bausch Health
9.14.1 Bausch Health Opioid Induced Constipation (OIC) Drugs Basic Information
9.14.2 Bausch Health Opioid Induced Constipation (OIC) Drugs Product Overview
9.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.14.4 Bausch Health Business Overview
9.14.5 Bausch Health Recent Developments
9.15 Cosmo Pharmaceuticals SA
9.15.1 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Basic Information
9.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product Overview
9.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.15.4 Cosmo Pharmaceuticals SA Business Overview
9.15.5 Cosmo Pharmaceuticals SA Recent Developments
9.16 Daewoong Pharmaceutical
9.16.1 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Basic Information
9.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product Overview
9.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.16.4 Daewoong Pharmaceutical Business Overview
9.16.5 Daewoong Pharmaceutical Recent Developments
9.17 C.B. Fleet Company
9.17.1 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Basic Information
9.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product Overview
9.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.17.4 C.B. Fleet Company Business Overview
9.17.5 C.B. Fleet Company Recent Developments
9.18 Sucampo Pharmaceuticals
9.18.1 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Basic Information
9.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Overview
9.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Market Performance
9.18.4 Sucampo Pharmaceuticals Business Overview
9.18.5 Sucampo Pharmaceuticals Recent Developments
10 Opioid Induced Constipation (OIC) Drugs Market Forecast by Region
10.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Forecast
10.2 Global Opioid Induced Constipation (OIC) Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Region
10.2.4 South America Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Opioid Induced Constipation (OIC) Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Opioid Induced Constipation (OIC) Drugs by Type (2025-2030)
11.1.2 Global Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Opioid Induced Constipation (OIC) Drugs by Type (2025-2030)
11.2 Global Opioid Induced Constipation (OIC) Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Opioid Induced Constipation (OIC) Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Opioid Induced Constipation (OIC) Drugs Market Size Comparison by Region (M USD)
Table 5. Global Opioid Induced Constipation (OIC) Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Opioid Induced Constipation (OIC) Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drugs as of 2022)
Table 10. Global Market Opioid Induced Constipation (OIC) Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Opioid Induced Constipation (OIC) Drugs Sales Sites and Area Served
Table 12. Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type
Table 13. Global Opioid Induced Constipation (OIC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Opioid Induced Constipation (OIC) Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioid Induced Constipation (OIC) Drugs Market Challenges
Table 22. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (Kilotons)
Table 23. Global Opioid Induced Constipation (OIC) Drugs Market Size by Type (M USD)
Table 24. Global Opioid Induced Constipation (OIC) Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Opioid Induced Constipation (OIC) Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Opioid Induced Constipation (OIC) Drugs Market Size Share by Type (2019-2024)
Table 28. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Opioid Induced Constipation (OIC) Drugs Sales (Kilotons) by Application
Table 30. Global Opioid Induced Constipation (OIC) Drugs Market Size by Application
Table 31. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Opioid Induced Constipation (OIC) Drugs Market Share by Application (2019-2024)
Table 35. Global Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Opioid Induced Constipation (OIC) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Basic Information
Table 44. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Overview
Table 45. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Ironwood Pharmaceuticals Inc Business Overview
Table 47. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs SWOT Analysis
Table 48. Ironwood Pharmaceuticals Inc Recent Developments
Table 49. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Basic Information
Table 50. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Overview
Table 51. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Daiichi Sankyo Co Ltd Business Overview
Table 53. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs SWOT Analysis
Table 54. Daiichi Sankyo Co Ltd Recent Developments
Table 55. Pfizer Opioid Induced Constipation (OIC) Drugs Basic Information
Table 56. Pfizer Opioid Induced Constipation (OIC) Drugs Product Overview
Table 57. Pfizer Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Opioid Induced Constipation (OIC) Drugs SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Basic Information
Table 62. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Overview
Table 63. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Progenics Pharmaceuticals Inc Business Overview
Table 65. Progenics Pharmaceuticals Inc Recent Developments
Table 66. Shionogi and Co., Ltd Opioid Induced Constipation (OIC) Drugs Basic Information
Table 67. Shionogi and Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Overview
Table 68. Shionogi and Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Shionogi and Co., Ltd Business Overview
Table 70. Shionogi and Co., Ltd Recent Developments
Table 71. Allergan Plc Opioid Induced Constipation (OIC) Drugs Basic Information
Table 72. Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Overview
Table 73. Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Allergan Plc Business Overview
Table 75. Allergan Plc Recent Developments
Table 76. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Basic Information
Table 77. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Overview
Table 78. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Nektar Therapeutics Business Overview
Table 80. Nektar Therapeutics Recent Developments
Table 81. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Basic Information
Table 82. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Overview
Table 83. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Purdue Pharma Business Overview
Table 85. Purdue Pharma Recent Developments
Table 86. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Basic Information
Table 87. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product Overview
Table 88. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. S.L.A. Pharma AG Business Overview
Table 90. S.L.A. Pharma AG Recent Developments
Table 91. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Basic Information
Table 92. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Overview
Table 93. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Mundipharma International Limited Business Overview
Table 95. Mundipharma International Limited Recent Developments
Table 96. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Basic Information
Table 97. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Overview
Table 98. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Ono Pharmaceutical Co., Ltd Business Overview
Table 100. Ono Pharmaceutical Co., Ltd Recent Developments
Table 101. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Basic Information
Table 102. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product Overview
Table 103. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Takeda Pharmaceutical Company Limited Business Overview
Table 105. Takeda Pharmaceutical Company Limited Recent Developments
Table 106. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Basic Information
Table 107. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product Overview
Table 108. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Theravance Biopharma Inc Business Overview
Table 110. Theravance Biopharma Inc Recent Developments
Table 111. Bausch Health Opioid Induced Constipation (OIC) Drugs Basic Information
Table 112. Bausch Health Opioid Induced Constipation (OIC) Drugs Product Overview
Table 113. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Bausch Health Business Overview
Table 115. Bausch Health Recent Developments
Table 116. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Basic Information
Table 117. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product Overview
Table 118. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Cosmo Pharmaceuticals SA Business Overview
Table 120. Cosmo Pharmaceuticals SA Recent Developments
Table 121. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Basic Information
Table 122. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product Overview
Table 123. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Daewoong Pharmaceutical Business Overview
Table 125. Daewoong Pharmaceutical Recent Developments
Table 126. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Basic Information
Table 127. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product Overview
Table 128. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. C.B. Fleet Company Business Overview
Table 130. C.B. Fleet Company Recent Developments
Table 131. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Basic Information
Table 132. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Overview
Table 133. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Sucampo Pharmaceuticals Business Overview
Table 135. Sucampo Pharmaceuticals Recent Developments
Table 136. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Opioid Induced Constipation (OIC) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Opioid Induced Constipation (OIC) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Opioid Induced Constipation (OIC) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Opioid Induced Constipation (OIC) Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Opioid Induced Constipation (OIC) Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Opioid Induced Constipation (OIC) Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioid Induced Constipation (OIC) Drugs Market Size (M USD), 2019-2030
Figure 5. Global Opioid Induced Constipation (OIC) Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Opioid Induced Constipation (OIC) Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioid Induced Constipation (OIC) Drugs Market Size by Country (M USD)
Figure 11. Opioid Induced Constipation (OIC) Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers in 2023
Figure 13. Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Opioid Induced Constipation (OIC) Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Opioid Induced Constipation (OIC) Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Opioid Induced Constipation (OIC) Drugs Market Share by Type
Figure 18. Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Type in 2023
Figure 20. Market Size Share of Opioid Induced Constipation (OIC) Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Opioid Induced Constipation (OIC) Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Opioid Induced Constipation (OIC) Drugs Market Share by Application
Figure 24. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2023
Figure 26. Global Opioid Induced Constipation (OIC) Drugs Market Share by Application (2019-2024)
Figure 27. Global Opioid Induced Constipation (OIC) Drugs Market Share by Application in 2023
Figure 28. Global Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Opioid Induced Constipation (OIC) Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Opioid Induced Constipation (OIC) Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country in 2023
Figure 37. Germany Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region in 2023
Figure 44. China Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Opioid Induced Constipation (OIC) Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Opioid Induced Constipation (OIC) Drugs Market Share Forecast by Application (2025-2030)
